24103121

Zhao XM

2013

[Study on the facial and body terminal hair growth in women in Guangdong by using modified Ferriman-Gallwey scoring system].

24105071

Cheng Q

2013

Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome.

24105072

Romualdi D

2013

Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.

24105073

Pasquali R

2013

Glucose intolerance states in women with the polycystic ovary syndrome.

24106282

Louwers YV

2013

Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome.

24107731

Armeni E

2013

Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.

24107826

Dudnyikova A

2013

[Endometrial cancer in young patients: report of 17 cases].

24108379

Arcana R

2013

[Colonic intussusception by leiomyosarcoma].

24112529

Malloch L

2013

An assessment of current clinical attitudes toward letrozole use in reproductive endocrinology practices.

24112745

Petraglia F

2013

The changing prevalence of infertility.

24114008

Hoirisch-Clapauch S

2013

Mental disorders and thrombotic risk.

24114630

Tumu VR

2013

An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women.

24116069

Rajender S

2013

Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS).

24118179

Zhang H

2014

Van Wyk and Grumbach syndrome: two case reports and review of the published work.

24118419

Hsiu H

2014

Differences in the skin-surface laser Doppler signals between polycystic ovary syndrome and normal subjects.

24120563

Dalamaga M

2013

Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.

24121067

Stanczyk FZ

2014

Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5?-reduced C19 conjugates in hyperandrogenic women.

24121378

Valsamakis G

2013

Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS).

24121689

Soleymani E

2014

Histopathological findings of endometrial specimens in abnormal uterine bleeding.

24126551

Orio F

2013

Effects of physical exercise on the female reproductive system.

24140258

Kyriacou A

2014

Gastric bypass surgery in women with or without polycystic ovary syndrome--a comparative observational cohort analysis.

24144083

Tao T

2013

Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome.

24144948

Huang QT

2013

Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.

24145507

Kumar A

2013

Adrenal ganglioneuroma in a patient with polycystic ovarian disease (PCOD): a rare association.

24146033

Della Torre S

2014

Energy metabolism and fertility: a balance preserved for female health.

24151290

Legro RS

2013

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

24152681

Tan BK

2013

Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome.

24152688

Puurunen J

2013

Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.

24156957

Legro RS

2014

The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial.

24157263

Ben-Salem A

2014

Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).

24157654

Yu YY

2013

Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients.

24158721

Papathanasiou A

2013

Comment on: Clomiphene Citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial. by Ghanem et al.

24158736

Asadi M

2014

Vitamin D improves endometrial thickness in PCOS women who need intrauterine insemination: a randomized double-blind placebo-controlled trial.

24160333

Nahuis MJ

2013

The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial.

24161302

Yildiz BO

2013

Polycystic ovary syndrome: is obesity a symptom?

24163207

Shen W

2013

Effects of tanshinone on hyperandrogenism and the quality of life in women with polycystic ovary syndrome: protocol of a double-blind, placebo-controlled, randomised trial.

24169034

Lin YH

2013

Hyperhomocysteinaemia is associated with biochemical hyperandrogenaemia in women with reproductive age.

24169035

Park SB

2013

Inhibitory effects of androstenedione on endometrial cells: implications for poor reproductive outcome among women with androgen excess.

24169251

Qin S

2013

[Expression and significance of ACE2-Ang-(1-7)-Mas axis in the endometrium of patients with polycystic ovary syndrome].

24170708

Mahoney D

2014

Lifestyle modification intervention among infertile overweight and obese women with polycystic ovary syndrome.

24172835

Gazi E

2013

Relationship of QT dispersion with sex hormones and insulin in young women with polycystic ovary syndrome: an observational study.

24173721

Merhi Z

2014

Advanced glycation end products and their relevance in female reproduction.

24173881

Comninos AN

2014

The relationship between gut and adipose hormones, and reproduction.

24178791

Teede H

2014

Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome.

24179868

Noorafshan A

2013

Stereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats.

24179872

Hwang YI

2013

Can high serum anti-M?llerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?

24183733

Shafiee MN

2014

Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?

24183950

Nascimbeni F

2014

Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?

24184282

Peign? M

2013

[Hyperandrogenism in women].

24186599

Milewicz A

2013

Metformin for polycystic ovary syndrome.

24188448

Farkas J

2014

Psychological aspects of the polycystic ovary syndrome.

24188449

Pantasri T

2014

The effects of being overweight and obese on female reproduction: a review.

24188871

Christ JP

2014

Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.

24188875

Shayya RF

2014

Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.

24189751

Heimark D

2014

Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls.

24191394

Terzieva DD

2013

Serum melatonin in women with polycystic ovary syndrome.

24192663

Fu LY

2014

Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.

24194682

Kucur C

2013

Extended high frequency audiometry in polycystic ovary syndrome.

24196302

Makled AK

2014

Assessment of ovarian stromal blood flow after metformin treatment in women with polycystic ovary syndrome.

24200988

Amisi C

2013

[Biological insulin resistance in Congolese woman with polycystic ovary syndrome (PCOS)].

24201678

Austin SL

2013

Menorrhagia in patients with type I glycogen storage disease.

24203060

Malin SK

2014

Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic ?-cell dysfunction in polycystic ovary syndrome.

24210236

Thomassin-Naggara I

2013

[MRI and CT-scan in presumed benign ovarian tumors].

24210439

Kaproth-Joslin K

2013

Imaging of female infertility: a pictorial guide to the hysterosalpingography, ultrasonography, and magnetic resonance imaging findings of the congenital and acquired causes of female infertility.

24215853

Detti L

2014

Ultrasound assessment of uterine cavity remodeling after surgical correction of subseptations.

24217570

de Sousa RM

2013

[Metabolic profile in women of different body mass indices with polycystic ovary syndrome].

24217571

de S? JC

2013

[Heart rate variability as a method of assessing the autonomic nervous system in polycystic ovary syndrome].

24219732

Gateva A

2013

NT-proBNP levels in premenopausal women with polycystic ovarian syndrome and/or obesity.

24224860

Altinok ML

2014

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study.

24228029

Talaei A

2013

Idiopathic hirsutism and insulin resistance.

24237181

U?ar A

2014

Pelvic ultrasound findings in prepubertal girls with precocious adrenarche born appropriate for gestational age.

24238271

Dewailly D

2014

Ultrasound definition of polycystic ovarian morphology: good news and bad news.

24240117

Sprung VS

2013

Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness.

24243639

Amato MC

2014

No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus.

24245018

Streuli I

2013

[Measurement of serum AMH levels in gynecology: indications and limits].

24245485

Yasmin E

2013

British Fertility Society. 'Ovulation induction in WHO Type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS Policy and Practice Committee.

24246334

Tock L

2014

Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome.

24249816

Inge TH

2013

The effect of obesity in adolescence on adult health status.

24256373

Sikar Akt?rk A

2014

The effects of isotretinoin on the ovarian reserve of females with acne.

24256515

Kahal H

2014

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease.

24258306

Huang R

2014

Variations in different polycystic ovary syndrome phenotypes in a population of Chinese Han.

24260211

Sun J

2013

Effects of electro-acupuncture on ovarian P450arom, P450c17? and mRNA expression induced by letrozole in PCOS rats.

24260388

Comim FV

2013

Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome.

24260557

Wang D

2013

Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.

24260593

Du D

2013

The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis.

24260609

Bu Z

2013

Overweight and obesity adversely affect outcomes of assisted reproductive technologies in polycystic ovary syndrome patients.

24262071

Reynolds-May MF

2014

Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls.

24268702

Nahuis MJ

2014

Pregnancy complications and metabolic disease in women with clomiphene citrate-resistant anovulation randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotropins: a 10-year follow-up.

24272197

Pasquali R

2014

Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome.

24272388

Hendrix AO

2014

Modeling endocrine control of the pituitary-ovarian axis: androgenic influence and chaotic dynamics.

24273971

Liu Y

2013

[Effect of danzhi xiaoyao pill on ovulation induction of polycystic ovarian syndrome patients of pathogenic fire derived from stagnation of gan-qi].

24274091

Zueff LN

2015

Body composition characteristics predict sexual functioning in obese women with or without PCOS.

24275746

Escobar-Morreale HF

2014

Reproductive endocrinology: Menstrual dysfunction--a proxy for insulin resistance in PCOS?

24276425

Dahan MH

2014

Twice-daily dosing of gonadotropins does not improve embryo quality during in vitro fertilization cycles in women with polycystic ovary syndrome, when compared to once-daily dosing: a pilot study.

24278193

Dowling AR

2013

Genetic factors modulate the impact of pubertal androgen excess on insulin sensitivity and fertility.

24278732

Avisar I

2012

The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension.

24279306

Huang X

2013

RUNX2, GPX3 and PTX3 gene expression profiling in cumulus cells are reflective oocyte/embryo competence and potentially reliable predictors of embryo developmental competence in PCOS patients.

24280645

Vargas-Diez E

2014

Azelaic acid in the treatment of acne in adult females: case reports.

24281956

Haase M

2013

[Hyperandrogenemia].

24282037

Tirabassi G

2014

Harmful effects of functional hypercortisolism: a working hypothesis.